ARGX NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

argenx NV ADR · Healthcare · Biotechnology

Open interactive chart View report data Download investor PDF
Latest close 918.2 USD
6.7% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 12.8% above the Trend Line and sits at 90.3% of its 52-week range. The latest completed week returned 6.7%, after a 3.5% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is bearish with 51/100 conviction, while the latest news-sentiment score is 60/100. Near-term considerations: price is close to its 52-week high; earnings are due in 0d.

Setup score 60 out of 100
Latest Close 918.2 USD 24 Jul 2026
1W Return 6.7% latest completed week
4W Return 3.5% short-term follow-through
12W Return 17.2% quarterly tape
Trend Breadth 61.5% 32 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 11 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 6.7% Latest completed week; four-week move 3.5%. Indicator stack 51/60 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bearish 51/100 conviction; expected move 8.6%. News sentiment 60/100 54 relevant articles in the latest sentiment read. Event risk 0d Next report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 12.8% above the Trend Line and sits at 90.3% of its 52-week range. The latest completed week returned 6.7%, after a 3.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6912-week average 0.40

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.69Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1111 reversal markers

No recent accumulation markers. 11 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.5% over four weeks, 17.2% over 12 weeks, and 55.1% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W6.7%
4W3.5%
12W17.2%
26W12.7%
52W55.1%
Active trend streak5 weeks
Active weeks in one year32
Trend breadth61.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.73Latest activity-pressure read.
Pressure change-35.8%Four-week change in activity pressure.
Leadership4.62Latest relative-leadership reading.
RS change960.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 97% Model confidence 97%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength42/100Blend of value, momentum, and quality. Underlying universe rank 59; rank 1 is best.
Value6/100Relative valuation strength. Underlying universe rank 95; rank 1 is best.
Quality84/100Profitability and accounting quality. Underlying universe rank 17; rank 1 is best.
Momentum87/100Medium-term price momentum. Underlying universe rank 14; rank 1 is best.
Growth97/100Revenue and earnings growth. Underlying universe rank 4; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework41/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
22.1x
Price divided by trailing earnings.
Price / sales
8.0x
Market value relative to trailing revenue.
EV / EBITDA
23.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
1.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
106.5%
Gross profit retained from each unit of revenue.
Operating margin
26.5%
Operating profit retained from revenue.
Free-cash-flow margin
12.0%
Free cash flow generated from revenue.
Return on invested capital
29.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
95.3%
Latest one-year revenue growth.
EPS growth
89.2%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

ARGX shows bearish options pressure with a 51/100 conviction score, put-call volume ratio of 5.10, expected move of 8.6%, and Sharemaestro trend signal active.

Conviction51/100
Expected move8.6%
Put/call volume5.10
Pressure-64
Speculation32
Volatility60
Trend agreement44
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment60/100

Weighted news tone is neutral across 54 relevant articles.

28 positive · 25 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings0dNext report is scheduled for 30 Jul 2026; event risk rises as the date approaches.
Options expected move8.6%Nearest-chain priced movement where available.
52-week drawdown-3.7%Distance below the 52-week high.
13-week volatility3.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher16 of 2610 weeks finished lower.
Best week+8.0%Week of 3 Apr.
Worst week-9.2%Week of 27 Feb.
Latest week+6.7%Week of 24 Jul.

Shape of recent returns

Strong gains7
Modest gains9
Flat weeks0
Modest losses5
Sharp losses5
Recent vol3.6%13-week weekly-return volatility.
Base vol4.8%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew4.2% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape58/100

Trend, activity pressure, participation, and risk combine to a 58/100 tape read.

 Indicator analysis47/100

Latest 12-week confirmation: trend 5/12, activity pressure 11/12, relative leadership 3/12.

Activity pressure 0.69; 11 reversal markers Factors53/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 61 SVQF41/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 429.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options37/100

ARGX shows bearish options pressure with a 51/100 conviction score, put-call volume ratio of 5.10, expected move of 8.6%, and Sharemaestro trend signal active.

Bearish · Put-side pressure · Expected move 8.6% Sentiment60/100

Weighted news tone is neutral across 54 relevant articles.

argenx (ENXTBR:ARGX) Could Be 15% Above Fair Value On The Forte Deal Insiders50/100

No recent insider transaction evidence is stored.

 Earnings0d

Next report is scheduled for 30 Jul 2026; event risk rises as the date approaches.

 Research flow1 items

1 recent research articles and 0 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026918.2 USD6.7%814.4 USD607.0 USD0.734.621.6MOn
17 Jul 2026860.5 USD-1.9%811.9 USD604.4 USD0.89-3.091.3MOn
10 Jul 2026877.6 USD-6.6%811.7 USD602.4 USD1.04-4.961.5MOn
3 Jul 2026939.7 USD5.9%811.7 USD599.2 USD1.163.921.4MOn
26 Jun 2026887.2 USD1.1%810.5 USD595.6 USD1.14-0.542.7MOn
19 Jun 2026877.7 USD-1.8%811.3 USD592.4 USD0.84-5.691.3MOff
12 Jun 2026893.5 USD0.2%812.7 USD589.3 USD0.71-1.201.8MOff
5 Jun 2026891.3 USD6.6%813.1 USD586.2 USD0.501.052.0MOff
29 May 2026836.0 USD3.7%811.9 USD583.0 USD0.26-9.28794.9KOff
22 May 2026806.5 USD0.9%811.3 USD580.1 USD0.18-9.921.6MOff
15 May 2026799.3 USD2.2%811.7 USD577.6 USD0.02-9.681.7MOff
8 May 2026782.2 USD-0.2%813.2 USD575.1 USD-0.09-11.852.0MOff
1 May 2026783.5 USD0.4%813.7 USD572.7 USD-0.25-6.891.5MOff
24 Apr 2026780.2 USD-8.1%814.2 USD570.3 USD-0.46-6.091.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.